Fig. 1From: A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritisForest plots of RORs for DAS 28 and CDAI for the assessment of low disease activity for comparisons of IL-6 inhibitors versus placebo (A) or active controls (B)Back to article page